{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:04:50Z","timestamp":1791317090353,"version":"4.3.1"},"reference-count":102,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Pediatric Neurology"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.spen.2006.01.007","type":"journal-article","created":{"date-parts":[[2006,7,7]],"date-time":"2006-07-07T00:01:27Z","timestamp":1152230487000},"page":"21-26","source":"Crossref","is-referenced-by-count":65,"title":["The Genetic and Molecular Pathogenesis of NF1 and NF2"],"prefix":"10.1016","volume":"13","author":[{"given":"Kaleb H.","family":"Yohay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.spen.2006.01.007_bib1","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1056\/NEJM199411243312102","article-title":"Neurofibromatosis type 1 due to germ-line mosaicism in a clinically normal father","volume":"331","author":"Lazaro","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.spen.2006.01.007_bib2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/jmg.27.5.307","article-title":"Segregation analysis of peripheral neurofibromatosis (NF1)","volume":"27","author":"Littler","year":"1990","journal-title":"J Med Genet"},{"key":"10.1016\/j.spen.2006.01.007_bib3","first-page":"841","article-title":"A genetic study of type 2 neurofibromatosis in the United Kingdom","volume":"29","author":"Evans","year":"1992","journal-title":"I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity J Med Genet"},{"key":"10.1016\/j.spen.2006.01.007_bib4","first-page":"284","article-title":"Penetrance of von Recklinghausen neurofibromatosis","volume":"42","author":"Riccardi","year":"1988","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.spen.2006.01.007_bib5","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/(SICI)1098-1004(1997)9:5<458::AID-HUMU13>3.0.CO;2-1","article-title":"Deletions spanning the neurofibromatosis type 1 gene","volume":"9","author":"Cnossen","year":"1997","journal-title":"Hum Mutat"},{"key":"10.1016\/j.spen.2006.01.007_bib6","first-page":"424","article-title":"Deletions spanning the neurofibromatosis 1 gene","volume":"54","author":"Kayes","year":"1994","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.spen.2006.01.007_bib7","first-page":"331","article-title":"Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease","volume":"59","author":"Ruttledge","year":"1996","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.spen.2006.01.007_bib8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1086\/422700","article-title":"Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2","volume":"75","author":"Baser","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.spen.2006.01.007_bib9","first-page":"847","article-title":"A genetic study of type 2 neurofibromatosis in the United Kingdom","volume":"29","author":"Evans","year":"1992","journal-title":"II. Guidelines for genetic counselling J Med Genet"},{"key":"10.1016\/j.spen.2006.01.007_bib10","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/356713a0","article-title":"Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients","volume":"356","author":"Basu","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.spen.2006.01.007_bib11","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1212\/WNL.56.12.1766","article-title":"Mononeuropathy multiplex as the initial manifestation of neurofibromatosis type 2","volume":"56","author":"Gijtenbeek","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2006.01.007_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1126\/science.2134734","article-title":"Type 1 neurofibromatosis gene","volume":"249","author":"Wallace","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.spen.2006.01.007_bib13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0092-8674(92)90407-4","article-title":"Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis","volume":"69","author":"DeClue","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.spen.2006.01.007_bib14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0092-8674(92)90408-5","article-title":"Somatic mutations in the neurofibromatosis 1 gene in human tumors","volume":"69","author":"Li","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.spen.2006.01.007_bib15","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/ng1194-218","article-title":"Screening for truncated NF1 proteins","volume":"8","author":"Heim","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.spen.2006.01.007_bib16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0092-8674(90)90252-A","article-title":"Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus","volume":"62","author":"Viskochil","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.spen.2006.01.007_bib17","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0092-8674(90)90024-9","article-title":"The neurofibromatosis type 1 gene encodes a protein related to GAP","volume":"62","author":"Xu","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.spen.2006.01.007_bib18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/jmg.33.1.2","article-title":"Molecular genetics of neurofibromatosis type 1 (NF1)","volume":"33","author":"Shen","year":"1996","journal-title":"J Med Genet"},{"key":"10.1016\/j.spen.2006.01.007_bib19","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/0888-7543(91)90410-G","article-title":"cDNA sequence and genomic structure of EV12B, a gene lying within an intron of the neurofibromatosis type 1 gene","volume":"9","author":"Cawthon","year":"1991","journal-title":"Genomics"},{"key":"10.1016\/j.spen.2006.01.007_bib20","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0888-7543(90)90199-5","article-title":"Identification and characterization of transcripts from the neurofibromatosis 1 region","volume":"7","author":"Cawthon","year":"1990","journal-title":"Genomics"},{"key":"10.1016\/j.spen.2006.01.007_bib21","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1128\/MCB.11.2.906","article-title":"The gene encoding the oligodendrocyte-myelin glycoprotein is embedded within the neurofibromatosis type 1 gene","volume":"11","author":"Viskochil","year":"1991","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.spen.2006.01.007_bib22","doi-asserted-by":"crossref","first-page":"9658","DOI":"10.1073\/pnas.88.21.9658","article-title":"Identification of the neurofibromatosis type 1 gene product","volume":"88","author":"Gutmann","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.spen.2006.01.007_bib23","doi-asserted-by":"crossref","first-page":"9914","DOI":"10.1073\/pnas.88.22.9914","article-title":"Identification and characterization of the neurofibromatosis type 1 protein product","volume":"88","author":"DeClue","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.spen.2006.01.007_bib24","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/j.1460-2075.1993.tb05841.x","article-title":"Characterization of full-length neurofibromin","volume":"12","author":"Bollag","year":"1993","journal-title":"EMBO J"},{"key":"10.1016\/j.spen.2006.01.007_bib25","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0896-6273(93)90324-K","article-title":"The neurofibromatosis type 1 gene and its protein product, neurofibromin","volume":"10","author":"Gutmann","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.spen.2006.01.007_bib26","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0896-6273(92)90270-N","article-title":"The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes","volume":"8","author":"Daston","year":"1992","journal-title":"Neuron"},{"key":"10.1016\/j.spen.2006.01.007_bib27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF01233074","article-title":"Neurofibromatosis type 1 gene product (neurofibromin) associates with microtubules","volume":"19","author":"Gregory","year":"1993","journal-title":"Somat Cell Mol Genet"},{"key":"10.1016\/j.spen.2006.01.007_bib28","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/0006-291X(91)92029-J","article-title":"Brain tumors predominantly express the neurofibromatosis type 1 gene transcripts containing the 63 base insert in the region coding for GTPase activating protein-related domain","volume":"181","author":"Suzuki","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.spen.2006.01.007_bib29","first-page":"1555","article-title":"Differential expression of two types of the neurofibromatosis type 1 (NF1) gene transcripts related to neuronal differentiation","volume":"6","author":"Nishi","year":"1991","journal-title":"Oncogene"},{"key":"10.1016\/j.spen.2006.01.007_bib30","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/1523-1747.ep12379925","article-title":"Localization of neurofibromin to keratinocytes and melanocytes in developing rat and human skin","volume":"102","author":"Malhotra","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.spen.2006.01.007_bib31","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/ng1194-218","article-title":"Screening for truncated NF1 proteins","volume":"8","author":"Heim","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.spen.2006.01.007_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1096-8628(19990326)89:1<1::AID-AJMG3>3.0.CO;2-8","article-title":"Epidemiology of neurofibromatosis type 1","volume":"89","author":"Friedman","year":"1999","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.spen.2006.01.007_bib33","first-page":"266","article-title":"Molecular biology of the neurofibromatoses","volume":"12","author":"Riccardi","year":"1993","journal-title":"Semin Dermatol"},{"key":"10.1016\/j.spen.2006.01.007_bib34","first-page":"305","article-title":"An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1)","volume":"53","author":"Easton","year":"1993","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.spen.2006.01.007_bib35","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/hmg\/4.6.975","article-title":"Distribution of 13 truncating mutations in the neurofibromatosis 1 gene","volume":"4","author":"Heim","year":"1995","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.spen.2006.01.007_bib36","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/jmg.35.10.813","article-title":"Neurofibromatosis type 1 (NF1)","volume":"35","author":"Park","year":"1998","journal-title":"J Med Genet"},{"key":"10.1016\/j.spen.2006.01.007_bib37","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/1098-1004(200006)15:6<541::AID-HUMU6>3.0.CO;2-N","article-title":"Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects","volume":"15","author":"Messiaen","year":"2000","journal-title":"Hum Mutat"},{"key":"10.1016\/j.spen.2006.01.007_bib38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.nbd.2004.01.006","article-title":"Genetic and phenotypic characterization of tumor cells derived from malignant peripheral nerve sheath tumors of neurofibromatosis type 1 patients","volume":"16","author":"Frahm","year":"2004","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.spen.2006.01.007_bib39","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0925-5710(98)00033-4","article-title":"Loss of heterozygosity of NF1 gene in juvenile chronic myelogenous leukemia with neurofibromatosis type 1","volume":"68","author":"Kai","year":"1998","journal-title":"Int J Hematol"},{"key":"10.1016\/j.spen.2006.01.007_bib40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/gcc.2870100109","article-title":"Loss of neurofibromin in adrenal gland tumors from patients with neurofibromatosis type I","volume":"10","author":"Gutmann","year":"1994","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.spen.2006.01.007_bib41","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1365-2990.2000.00258.x","article-title":"Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas","volume":"26","author":"Gutmann","year":"2000","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.spen.2006.01.007_bib42","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1212\/WNL.61.10.1397","article-title":"Molecular analysis of astrocytomas presenting after age 10 in individuals with NF1","volume":"61","author":"Gutmann","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2006.01.007_bib43","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/ng0995-90","article-title":"Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene","volume":"11","author":"Colman","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.spen.2006.01.007_bib44","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ng0996-110","article-title":"Identification of NF1 mutations in both alleles of a dermal neurofibroma","volume":"14","author":"Sawada","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.spen.2006.01.007_bib45","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1086\/515504","article-title":"Confirmation of a double-hit model for the NF1 gene in benign neurofibromas","volume":"61","author":"Serra","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.spen.2006.01.007_bib46","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/(SICI)1098-2264(199903)24:3<283::AID-GCC15>3.0.CO;2-K","article-title":"Loss of NF1 allele in Schwann cells but not in fibroblasts derived from an NF1-associated neurofibroma","volume":"24","author":"Kluwe","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.spen.2006.01.007_bib47","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cancergencyto.2004.04.019","article-title":"A case of neurofibromatosis and breast cancer","volume":"156","author":"Guran","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.spen.2006.01.007_bib48","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1136\/gut.2004.053348","article-title":"NF1 gene loss of heterozygosity and expression analysis in sporadic colon cancer","volume":"54","author":"Cacev","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.spen.2006.01.007_bib49","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0165-4608(96)00259-2","article-title":"Homozygous deletion of the neurofibromatosis-1 gene in the tumor of a patient with neuroblastoma","volume":"95","author":"Martinsson","year":"1997","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.spen.2006.01.007_bib50","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1084\/jem.191.1.181","article-title":"Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo","volume":"191","author":"Ingram","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.spen.2006.01.007_bib51","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0006-8993(98)01133-0","article-title":"Region-specific astrogliosis in brains of mice heterozygous for mutations in the neurofibromatosis type 1 (Nf1) tumor suppressor","volume":"816","author":"Rizvi","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.spen.2006.01.007_bib52","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/00005072-199507000-00013","article-title":"Neurofibromin expression and astrogliosis in neurofibromatosis (type 1) brains","volume":"54","author":"Nordlund","year":"1995","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.spen.2006.01.007_bib53","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1038\/sj.onc.1202829","article-title":"Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation","volume":"18","author":"Gutmann","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.spen.2006.01.007_bib54","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/1098-1136(20010315)33:4<314::AID-GLIA1030>3.0.CO;2-Q","article-title":"Neurofibromatosis 1 (NF1) heterozygosity results in a cell-autonomous growth advantage for astrocytes","volume":"33","author":"Bajenaru","year":"2001","journal-title":"Glia"},{"key":"10.1016\/j.spen.2006.01.007_bib55","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1093\/hmg\/10.26.3009","article-title":"Heterozygosity for the neurofibromatosis 1 (NF1) tumor suppressor results in abnormalities in cell attachment, spreading and motility in astrocytes","volume":"10","author":"Gutmann","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.spen.2006.01.007_bib56","first-page":"4682","article-title":"ras oncogenes in human cancer","volume":"49","author":"Bos","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/j.spen.2006.01.007_bib57","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/351576a0","article-title":"Differential regulation of rasGAP and neurofibromatosis gene product activities","volume":"351","author":"Bollag","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.spen.2006.01.007_bib58","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/ng0296-144","article-title":"Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells","volume":"12","author":"Bollag","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.spen.2006.01.007_bib59","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3171\/jns.1996.84.5.0867","article-title":"Acute presentation of a neurogenic sarcoma in a patient with neurofibromatosis type 1: a pathological and molecular explanation. Case report","volume":"84","author":"Feldkamp","year":"1996","journal-title":"J Neurosurg"},{"key":"10.1016\/j.spen.2006.01.007_bib60","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1126\/science.276.5313.791","article-title":"Rescue of a Drosophila NF1 mutant phenotype by protein kinase A","volume":"276","author":"The","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.spen.2006.01.007_bib61","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.1073\/pnas.90.12.5539","article-title":"Inactivation of the NF1 gene in human melanoma and neuroblastoma cell lines without impaired regulation of GTP","volume":"90","author":"Johnson","year":"1993","journal-title":"Ras. Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.spen.2006.01.007_bib62","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0165-4608(82)90063-2","article-title":"Cytological and cytogenetical studies on human meningioma","volume":"6","author":"Zang","year":"1982","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.spen.2006.01.007_bib63","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/329246a0","article-title":"Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22","volume":"329","author":"Rouleau","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.spen.2006.01.007_bib64","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/363515a0","article-title":"Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2","volume":"363","author":"Rouleau","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.spen.2006.01.007_bib65","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0092-8674(93)90406-G","article-title":"A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor","volume":"72","author":"Trofatter","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.spen.2006.01.007_bib66","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1046\/j.1523-1747.2000.00975.x","article-title":"Mutations and allelic loss of the NF2 gene in neurofibromatosis 2-associated skin tumors","volume":"114","author":"Kluwe","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.spen.2006.01.007_bib67","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0165-4608(99)00201-0","article-title":"Neurofibromatosis 2 phenotypes and germ-line NF2 mutations determined by an RNA mismatch method and loss of heterozygosity analysis in NF2 schwannomas","volume":"118","author":"Hung","year":"2000","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.spen.2006.01.007_bib68","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/jnen\/59.6.504","article-title":"Allelic losses in neurofibromatosis 2-associated meningiomas","volume":"59","author":"Lamszus","year":"2000","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.spen.2006.01.007_bib69","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/labinvest.3700218","article-title":"Loss of heterozygosity on chromosome 22q in gastrointestinal stromal tumors (GISTs)","volume":"85","author":"Lasota","year":"2005","journal-title":"Lab Invest"},{"key":"10.1016\/j.spen.2006.01.007_bib70","first-page":"5995","article-title":"Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas","volume":"59","author":"Ueki","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.spen.2006.01.007_bib71","first-page":"955","article-title":"Concurrent LOH at multiple loci in human malignant mesothelioma with preferential loss of NF2 gene region","volume":"9","author":"Pylkkanen","year":"2002","journal-title":"Oncol Rep"},{"key":"10.1016\/j.spen.2006.01.007_bib72","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1134>3.0.CO;2-P","article-title":"Molecular genetic alterations on chromosomes 11 and 22 in ependymomas","volume":"91","author":"Lamszus","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.spen.2006.01.007_bib73","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/gcc.20141","article-title":"Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas","volume":"42","author":"Lomas","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.spen.2006.01.007_bib74","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-2443.2001.00432.x","article-title":"Identification of the cis-acting region in the NF2 gene promoter as a potential target for mutation and methylation-dependent silencing in schwannoma","volume":"6","author":"Kino","year":"2001","journal-title":"Genes Cells"},{"key":"10.1016\/j.spen.2006.01.007_bib75","first-page":"5601","article-title":"CpG island methylation in sporadic and neurofibromatis type 2-associated schwannomas","volume":"9","author":"Gonzalez-Gomez","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.spen.2006.01.007_bib76","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ajmg.1320520411","article-title":"Neurofibromatosis 2 (NF2)","volume":"52","author":"Parry","year":"1994","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.spen.2006.01.007_bib77","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/gepi.10181","article-title":"Intrafamilial correlation of clinical manifestations in neurofibromatosis 2 (NF2)","volume":"23","author":"Zhao","year":"2002","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.spen.2006.01.007_bib78","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/(SICI)1096-8628(19960906)64:4<563::AID-AJMG7>3.0.CO;2-Q","article-title":"Phenotypic variability in monozygotic twins with neurofibromatosis 2","volume":"64","author":"Baser","year":"1996","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.spen.2006.01.007_bib79","first-page":"529","article-title":"Germ-line mutations in the neurofibromatosis 2 gene","volume":"59","author":"Parry","year":"1996","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.spen.2006.01.007_bib80","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/jmg.2004.029504","article-title":"The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2","volume":"42","author":"Baser","year":"2005","journal-title":"J Med Genet"},{"key":"10.1016\/j.spen.2006.01.007_bib81","first-page":"314","article-title":"Mutational analysis of patients with neurofibromatosis 2","volume":"55","author":"Maccollin","year":"1994","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.spen.2006.01.007_bib82","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0968-0004(96)10071-2","article-title":"ERM proteins","volume":"22","author":"Tsukita","year":"1997","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.spen.2006.01.007_bib83","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0092-8674(00)80836-3","article-title":"Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain","volume":"101","author":"Pearson","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.spen.2006.01.007_bib84","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1107\/S0907444901021175","article-title":"The structure of the FERM domain of merlin, the neurofibromatosis type 2 gene product","volume":"58","author":"Kang","year":"2002","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.spen.2006.01.007_bib85","first-page":"10332","article-title":"Structural basis for neurofibromatosis type 2","volume":"277","author":"Shimizu","year":"2002","journal-title":"Crystal structure of the merlin FERM domain. J Biol Chem"},{"key":"10.1016\/j.spen.2006.01.007_bib86","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1038\/sj.onc.1201418","article-title":"Interdomain binding mediates tumor growth suppression by the NF2 gene product","volume":"15","author":"Sherman","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.spen.2006.01.007_bib87","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/(SICI)1097-4547(19991201)58:5<706::AID-JNR12>3.0.CO;2-Z","article-title":"Neurofibromatosis 2 tumor suppressor protein, merlin, forms two functionally important intramolecular associations","volume":"58","author":"Gutmann","year":"1999","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.spen.2006.01.007_bib88","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1038\/sj.onc.1201418","article-title":"Interdomain binding mediates tumor growth suppression by the NF2 gene product","volume":"15","author":"Sherman","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.spen.2006.01.007_bib89","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/hmg\/7.3.335","article-title":"Defects in neurofibromatosis 2 protein function can arise at multiple levels","volume":"7","author":"Gutmann","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.spen.2006.01.007_bib90","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1101\/gad.11.10.1253","article-title":"The Nf2 tumor suppressor gene product is essential for extraembryonic development immediately prior to gastrulation","volume":"11","author":"McClatchey","year":"1997","journal-title":"Genes Dev"},{"key":"10.1016\/j.spen.2006.01.007_bib91","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1101\/gad.12.8.1121","article-title":"Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors","volume":"12","author":"McClatchey","year":"1998","journal-title":"Genes Dev"},{"key":"10.1016\/j.spen.2006.01.007_bib92","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1101\/gad.13.8.978","article-title":"Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein","volume":"13","author":"Giovannini","year":"1999","journal-title":"Genes Dev"},{"key":"10.1016\/j.spen.2006.01.007_bib93","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1101\/gad.226302","article-title":"Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse","volume":"16","author":"Kalamarides","year":"2002","journal-title":"Genes Dev"},{"key":"10.1016\/j.spen.2006.01.007_bib94","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/hmg\/11.1.69","article-title":"Transduction of wild-type merlin into human schwannoma cells decreases schwannoma cell growth and induces apoptosis","volume":"11","author":"Schulze","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.spen.2006.01.007_bib95","first-page":"1493","article-title":"Overexpression of the NF2 gene inhibits schwannoma cell proliferation through promoting PDGFR degradation","volume":"23","author":"Fraenzer","year":"2003","journal-title":"Int J Oncol"},{"key":"10.1016\/j.spen.2006.01.007_bib96","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1101\/gad.189601","article-title":"The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44","volume":"15","author":"Morrison","year":"2001","journal-title":"Genes Dev"},{"key":"10.1016\/j.spen.2006.01.007_bib97","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3171\/jns.1999.91.1.0085","article-title":"Inhibition of NF2-negative and NF2-positive primary human meningioma cell proliferation by overexpression of merlin due to vector-mediated gene transfer","volume":"91","author":"Ikeda","year":"1999","journal-title":"J Neurosurg"},{"key":"10.1016\/j.spen.2006.01.007_bib98","doi-asserted-by":"crossref","first-page":"23387","DOI":"10.1016\/S0021-9258(17)31525-9","article-title":"An anti-Ras function of neurofibromatosis type 2 gene product (NF2\/Merlin)","volume":"269","author":"Tikoo","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.spen.2006.01.007_bib99","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/gcc.10282","article-title":"NF2","volume":"38","author":"Xiao","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.spen.2006.01.007_bib100","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1097-2765(03)00382-4","article-title":"Merlin, the product of the Nf2 tumor suppressor gene, is an inhibitor of the p21-activated kinase, Pak1","volume":"12","author":"Kissil","year":"2003","journal-title":"Mol Cell"},{"key":"10.1016\/j.spen.2006.01.007_bib101","doi-asserted-by":"crossref","first-page":"18200","DOI":"10.1073\/pnas.0405971102","article-title":"Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L","volume":"101","author":"Rong","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.spen.2006.01.007_bib102","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.1038\/sj.onc.1208633","article-title":"The merlin tumor suppressor interacts with Ral guanine nucleotide dissociation stimulator and inhibits its activity","volume":"24","author":"Ryu","year":"2005","journal-title":"Oncogene"}],"container-title":["Seminars in Pediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909106000118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909106000118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T05:10:12Z","timestamp":1627535412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071909106000118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":102,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S1071909106000118"],"URL":"https:\/\/doi.org\/10.1016\/j.spen.2006.01.007","relation":{},"ISSN":["1071-9091"],"issn-type":[{"value":"1071-9091","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}